Mulmit

Pelthos Therapeutics Inc.Pelthos Therapeutics Inc.

PTHS NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3116,795,000-32,430,000-43,319,000-23.04
2024-12-310-7,571,000-7,955,000-14.27

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-07-02Friedberg Ezra M534
2026-07-02Friedberg Ezra M24
2026-07-02Pauls Matthew692
2026-07-02Pauls Matthew94
2026-07-02Greenleaf Peter712
2026-07-02Greenleaf Peter85
2026-06-15Friedberg Ezra M224
2026-06-15Friedberg Ezra M59
2026-06-11Davis Todd C35,445
2026-06-11Davis Todd C503
2026-05-22Francis Knuettel IICFO, Treas & Secty13,947
2026-05-22Francis Knuettel IICFO, Treas & Secty1,500

8-K events

FiledItems
2026-08-13Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-08-13Non-reliance on previously issued financials
2026-05-28Regulation FD disclosure · Financial statements and exhibits
2026-05-21Change in certifying accountant · Officer or director change · Financial statements and exhibits
2026-05-14Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-04-14Regulation FD disclosure · Financial statements and exhibits
2026-04-10Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-03-19Results of operations · Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.